Recommendations of endocrine treatment for patients with gender dysphoria

Sexual and Relationship Therapy

Volumn 24, Issue 2, 2009, Pages 175-187

  Wylie, Kevan Richard ^a,b   Fung Jr , Robert ^c   Boshier, Claudia ^d   Rotchell, Margaret ^c  

^a Porterbrook Clinic   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c SHEFFIELD HEALTH AND SOCIAL CARE NHS FOUNDATION TRUST   (United Kingdom)

^d BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Endocrinology; Estrogen; Gender dysphoria; Gonadotrophin; Guidelines; Hormones; Testosterone

Indexed keywords

EID: 70350787039     PISSN: 14681994     EISSN: 14681749     Source Type: Journal    
DOI: 10.1080/14681990903023306     Document Type: Article

References (26)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (Revised 4th ed.). Washington, DC: Author.
2. Dahl, M., Feldman, J.L., Goldberg, J.M., & Jaberi, A. (2006). Physical aspects of transgender endocrine therapy. International Journal of Transgenderism, 9(3-4), 111-134.
3. Department of Health. (2007). A guide to hormone therapy for trans people (NHS). Retrieved April 22, 2009, from www.dh.gov.uk/en/publicationsandstatistics/publications/publicationsPolicyAndGuidance/DH_081580
4. Dittrich, R., Binder, H., Cupisti, S., Hoffman, I., Beckmann, M.W., & Mueller, A. (2005). Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Experimental & Clinical Endocrinology & Diabetes, 113(10), 586-592.
5. Dobs, A., & Moore, E. (2004). Letter to the editor: The endocrine care of transsexual people. Journal of Clinical Endocrinology and Metabolism, 89(2), 1015.
6. Futterweit, W. (1998). Endocrine therapy of transsexualism and potential complications of long-term treatment. Archives of Sexual Behavior, 27(2), 209-226.
7. Gooren, L. (2005). Hormonal treatment of the adult transsexual patient. Hormone Research, 64(2),31-36.
8. Green, R. (2000). Gender identity disorder in adults. In M. Gelder, J.J. Lopez-Ibor, & N.C. Andreasen (Eds.), New Oxford textbook of psychiatry. Oxford: Oxford University Press.
9. Greenspan, F., & Gardner, D. (2004). Basic and clinical endocrinology. Lange: McGraw-Hill Education.
10. Hage, J., Dekker, J., Karim, R., Verheijen, R., & Bloemena, E. (2000). Ovarian cancer in female-to-male transsexuals: Report of two cases. Gynecologic Oncology, 76(3), 413-415.
11. Joint Formulary Committee. (2008). British National Formulary (55th ed.). London: British Medical Association and Royal Pharmaceutical Society of Great Britain.
12. Meyer, W., Bockting, W., Cohen-Kettenis, P., Coleman, E., DiCeglie, D., Dever, H., et al. (2001). Harry Benjamin International Gender Dysphoria Association's Standards of Care for Gender Identity Disorders (6th ed.). Journal of Psychology and Human Sexuality, 13(1),1-30.
13. Levy, A., Crown, A., & Reid, R. (2003). Endocrine intervention for transsexuals. Clinical Endocrinology, 59, 409-418.
14. Michel, A., Mormont, C., & Legros, G. (2001). A psycho-endocrinological of transsexualism. European Journal of Endocrinology, 145, 365-376.
15. Moore, E., Wisniewski, A., & Dobs, A. (2003). Endocrine treatment of transsexual people: A review of treatment regimens, outcomes and adverse effects. Journal of Clinical Endocrinology and Metabolism, 88(8), 3467-3473.
16. Royal College of Psychiatrists. (2006). Good practice guidelines for the assessment and treatment of gender dysphoria - draft. Retrieved 22 April, 2009, from http://www.rcpsych.ac.uk/pdf/Standards%20of%20Care%20Draft%20v8%203b%20final.pdf
17. Ruetsche, A.G., Kneubuehl, R., Birkhaeuser, M.H., & Lippuner, K. (2005). Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormone treatment: A cross-sectional study. Osteoporosis International, 16, 791-798.
18. Schlatterer, K., von Werder, K., & Stalla, G.K. (1996). Multistep treatment concept of transsexual patients. Experimental and Clinical Endocrinology and Diabetes, 104, 413-419.
19. Seal, L.J. (2007). The practical management of hormone treatment in adults with gender dysphoria. In J. Barret (Ed.), Transsexual and other disorders of gender identity, a practical guide to arrangement. Oxford: Radcliff Publishing Ltd.
20. Tangpricha, V., Ducharme, S., Barber, T., & Chipkin, S. (2003). Endocrinological treatment of gender identity disorder. Endocrine Practices, 9(1), 12-21.
21. Toorians, A.W.F.T., Thomassen, M.C.L.G.D., Zweegman, S., Magdeleyns, E.J.P., Tans, G., Gooren, L.J.G., et al. (2003). Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. Journal of Clinical Endocrinology and Metabolism, 88(12), 5723-5729.
22. T'Sjoen, G., Rubens, R., De Sutter, P., & Gooren, L. (2004). Letter to the editor: The endocrine care of transsexual people. Journal of Clinical Endocrinology and Metabolism, 89(2),1014-1015.
23. Tugnet, N., Goddard, J.C., Vickery, R.M., Khoosal, D., & Terry, T.R. (2007). Current management of male-to-female gender identity disorder in the UK. Postgraduate Medical Journal, 83, 638-642.
24. van Kesteren, P.J., Asscheman, H., Megens, J.A., & Gooren, L.J. (1997). Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology, 47,337-342.
25. Vardi, Y., Wylie, K.R., Moser, C., Assalian, P., Dean, J., & Asscheman, H. (2008). Is physical examination required before prescribing hormones to patients with gender dysphoria? Journal of Sexual Medicine, 5, 21-26.
26. World Health Organisation. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: WHO.